Document Details
Form
Filing Date
Mar 3, 2020
Document Date
Mar 1, 2020
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
BioCryst Pharmaceuticals, Inc.
Issuer
BIOCRYST PHARMACEUTICALS INC
Filer
ASELAGE STEVE